# Levosimendan

## Simdax inj 12.5mg/5mL

| 藥物代碼 | ISIMD |
| :--- | :--- |
| 適應症 | Short-term treatment of acutely decompensated severe chronic heart failure \(ADHF\) wherein conventional therapy is not sufficient & in cases where inotropic support is appropriate. |
| 副作用 | Headache; ventricular tachycardia; hypotension. Hypokalaemia; insomnia; dizziness; atrial fibrillation, tachycardia, ventricular extrasystoles, cardiac failure, myocardial ischaemia, extrasystoles; nausea, constipation, diarrhoea, vomiting; decreased Hb. |
| 禁忌 | Hypersensitivity. Severe hypotension & tachycardia. Significant mechanical obstructions affecting ventricular filling or outflow or both. Severe renal impairment \(CrCl &lt;30 mL/min\) & severe hepatic impairment. History of Torsades de Pointes,  hypotension\(SBP&lt;100 mmHg或DBP&lt;60 mmHg\). |
| 懷孕用藥危分級 | 尚未確立 |
| 孕期用藥建議 | N/A |
| 附帶說明 | N/A |
| 哺乳期用藥建議 | Unknown 尚未建立 |
| 附帶說明 | N/A |
| 注射劑給藥建議途徑 | IVD |
| 乾粉稀釋液 | N/A |
| 輸注點滴液 | 【D5W】 可選 仿單建議 |
| IVP 用法建議 | X |
| IVD 用法建議 | Dilute to 0.025 - 0.05 mg/mL before administration. Initial bolus dose: 6-12 mcg/kg over 10 minutes. Continuous infusion dose: 0.05-0.2 mcg/kg/min. |
| 注意事項 | Lower loading dose of 6 mcg/kg is recommended in patients on concomitant IV vasodilators or inotropes or both at start of infusion. Rate of infusion may be decreased to 0.05 mcg/kg/min or discontinued if response is deemed excessive; may be increased to 0.2 mcg/kg/min if initial dose is tolerated. Duration of infusion: 24 hr. 稀釋後的藥品，其化學及物理安定性於25°C下可維持24小時。 對於急性失代償性嚴重慢性心衰竭病人的建議輸注時間為24小時。 |

